Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Use and Abuse of HOMA Modeling
2004 Standout
Establishing the Diagnosis of Lung Cancer
2013 Standout
Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes
1999
The Role of CT Pulmonary Angiography in the Investigation of Unilateral Pleural Effusions
2013 Standout
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
Imaging of Pleural Disease
2006
The biology and management of non-small cell lung cancer
2018 StandoutNature
Characterization of PET/CT images using texture analysis: the past, the present… any future?
2016
Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma
2004
Macrophages in immunoregulation and therapeutics
2023 Standout
High Performance of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography and Contrast-Enhanced CT in a Rapid Outpatient Diagnostic Program for Patients with Suspected Lung Cancer
2013 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Management of spontaneous pneumothorax: British Thoracic Society pleural disease guideline 2010
2010 Standout
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Radiology in pleural disease: State of the art
2004
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
Insulin and insulin resistance:
2004 Standout
Use of imaging in the management of malignant pleural mesothelioma
2005
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography
2008
The assessment of insulin resistance in man
2002
IgG4-related disease
2014 Standout
Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: A systematic review and meta-analysis
2009
Methods for Staging Non-small Cell Lung Cancer
2013
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
Short Sleep Duration Is Associated with Reduced Leptin, Elevated Ghrelin, and Increased Body Mass Index
2004 Standout
Staging of non-small cell lung cancer: consensus, controversies and challenges
2001
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
The Approach to the Patient with a Parapneumonic Effusion
2006
Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis
2017
Advances in Malignant Mesothelioma
2005 Standout
Metaanalyse zum Stellenwert der Positronen-Emissions-Tomographie mit F-18-Fluorodesoxyglukose (FDG-PET) bei Lungentumoren1 - Diskussionsbasis der deutschen Konsensus-Konferenz Onko-PET 2000 -
2001
Functional and postoperative outcomes after preoperative exercise training in patients with lung cancer: a systematic review and meta-analysis
2016
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
Macrophages Are a Double-Edged Sword: Molecular Crosstalk between Tumor-Associated Macrophages and Cancer Stem Cells
2022
Revised Response Criteria for Malignant Lymphoma
2007 Standout
Positron-Emission Tomography and Assessment of Cancer Therapy
2006
18F-FDG PET/CT Imaging In Oncology
2011
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
2005
Imaging of pleural disease
2004
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Works of Bernard Duysinx being referenced
Inhibition of EZH2 methyltransferase decreases immunoediting of mesothelioma cells by autologous macrophages through a PD-1–dependent mechanism
2019
Endobronchial ultrasound and value of PET for prediction of pathological results of mediastinal hot spots in lung cancer patients
2008
FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy
2016
Should we exclude elderly patients with chronic obstructive pulmonary disease from a long-time ambulatory pulmonary rehabilitation programme?
2012
Evaluation of Pleural Disease With 18-Fluorodeoxyglucose Positron Emission Tomography Imaging
2004
Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer
1999
[18FDG-PET applications in thoracic oncology].
2001
Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
2003
Measurement of insulin sensitivity by the minimal model method using a simplified intravenous glucose tolerance test: validity and reproducibility.
1995